Schering Plough news from FierceHealthcare
NewsWill 2009 be Consolidation Year for pharma?
With the giant union between Pfizer and Wyeth en route to being consummated, analysts are now speculating about other major mergers are to follow. Several think this could be the Year of Read more...
Drug companies plan to disclose grant funding
Hoping to stave off outside regulation by Congress, a group of the nation's largest drug and device manufacturers have put forth plans to publicly disclose the grants they make to outside Read more...
Congress says drugmakers held back Vytorin data
Cholesterol drug Vytorin--and makers Merck and Schering-Plough--have been under fire for months since a study suggested that the expensive combo med works no better than much less costly Zocor. Read more...
| Press ReleasesReprints Desk to Highlight Scientific Literature Licensing and Deployment Service at DigiPharm EuropeSANTA MONICA, Calif., Sept. 21 /PRNewswire/ -- Reprints Desk, Inc. today announced that the company will highlight the ePrints NRx scientific literature licensing and deployment service during its Read more >> Learn How Merck is Creating a Unified Culture and Company Brand During NewsGator Webinar Entitled: From MyMerck to OneMerck - EnDENVER, July 7 /PRNewswire/ -- Merck, the second-largest pharmaceutical company in the world with a long, rich history in working to improve people's health and well-being around the globe, will Read more >> Merck Highlights Robust Late-Stage Pipeline, Global Business Strategy and Progress of IntegrationCompany Anticipates Five NDA Filings in 2010 in Addition to the Four Currently Under Review in the United States and/or European UnionMerck's Late-Stage Pipeline Has More Than 20 New Candidates in Read more >> |
